Select a Region North America

Insights

Insights From Our Experts

Articles

Maximizing Product Launch Success: The Importance of Conducting Comprehensive Business Simulation Exercises

Product launch preparedness is a vital aspect of bringing new products to market, particularly in the pharmaceutical industry where patients’ health and well-being can be impacted, in addition to the brand’s success and overall reputation. As…

The Art of Simplifying Pharmacovigilance – Part IV: Streamlining Vendor Engagement for Marketing Authorization Holders

It is often overlooked how many vendors a Marketing Authorization Holder (MAH) engages with. The more you spread your resources, the more scattered your focus becomes. Conversely, the more you concentrate your efforts, the more you…

The Art of Simplifying Pharmacovigilance – Part III: Unlocking Efficiency Through Consolidation

Just a few years ago, accessing entertainment on television was simple. However, the emergence of Over The Top applications for streaming content has made it complex, requiring users to manage multiple accounts and subscriptions. Consequently, users…

The Art of Simplifying Pharmacovigilance – Part II: Change Adoption

Considerable effort is dedicated to inputting clean adverse event data into a safety database, even before conducting the analysis to extract insights. In this scenario, manufacturers are investing more resources in the process of inputting data…

The Art of Simplifying Pharmacovigilance – Part I: Connecting the Dots

The Art of Simplifying Pharmacovigilance – Part I: Connecting the Dots In the intricate realm of pharmacovigilance, there is an art — a delicate dance of connecting the dots. Like a skilled painter, vigilant professionals adeptly…

Commercial Key Success Factors (KSFs) for Global Drug Development Programs

Key Contributors: Swapnil Waichale, Principal and Robin Arnold, Executive Vice President Discover the essential commercial key success Factors (KSFs) that drive triumph in global drug development programs. In an era of diverse regulatory perspectives and reimbursement…

The Role of RWE in Expediting the Drug Approval Process
The Role of RWE in Expediting the Drug Approval Process

Key Contributors: Lydia Edison (Project Manager), Rohit Mandlik (Project Manager), Rohit Dang (Engagement Manager), Mahendra Rai (Senior Director) The role of real-world evidence (RWE) in expediting the drug approval process. RWE refers to the use of…

Unlocking the Power of Data, Artificial Intelligence and Digital Innovations to Revolutionize Care for Rare Disease Patients

Rare diseases and developing and distributing the therapies that treat them create highly complex challenges for pharmaceutical manufacturers, and certainly for the patients and providers impacted by them every day. Because these diseases are often extremely…

Biosimilars and Specialty Pharmacy
Specialty Pharmacies are Ready for the Biosimilar Boom. Are you?

The pharmacy benefit biologic market is primed for disruption, with Specialty Pharmacies (SPs) eagerly awaiting the pending market shift. While biosimilars have been available for nearly a decade in the United States, this year will be…

Position Your Future-Facing Strategy on Digital Therapeutics (DTx) in China

How can DTx resonate with current portfolios and capture incoming opportunities? Key Contributors: Robin Arnold, Executive Vice President; Jerry Song, Associate Principal; Qiwei (Alex) Li, Consultant   The article discusses the potential of digital therapeutics (DTx) in China’s healthcare…